Peripheral artery disease Market on target to reach $4,980 Million by 2023

Peripheral artery disease is a circulatory disease in which plaque builds up in the arteries carrying blood from heart to legs, arms, and other limbs. Increase in incidence of population suffering from diabetes and high blood pressure which poses a high risk factor for peripheral artery disease drives the market growth.

Global Peripheral Artery Disease Market was valued at $3,136 million in 2016, and is estimated to reach $4,980 million by 2023, growing at a CAGR of 6.8% from 2017 to 2023.

Request Sample Report @ https://www.alliedmarketresearch.com/request-sample/4315

Favorable reimbursement scenario for peripheral artery disease treatment and introduction of advanced treatment products such as drug-eluting stents boost the market growth. However, the issue of restenosis (reoccurrence of peripheral artery disease even after the treatment) impedes the market growth.

Peripheral stents segment is expected to dominate the market throughout the analysis period as these significantly reduce the risk associated with the build-up of plaque in the arteries. Plaque modification devices is expected to register highest CAGR of 7.6% during the forecast period.

Key Findings of the Peripheral Artery Disease Market:

• Atherectomy devices is projected to grow at a CAGR of 7.9% during the forecast period.
• Chronic total occlusion devices accounted for more than two-fifth of the share of the global peripheral artery disease market, in 2016.
• Aspiration thrombectomy segment is expected to register the highest CAGR of 10.3% during the analysis period.
• Drug-eluting stents is expected to grow at the CAGR of 7.7% during the forecast period.
• France and Germany collectively contributed for more than one-third share of the European peripheral artery disease market in 2016.
• Japan is the major shareholder, accounting for more than one-third share of the Asia-Pacific peripheral artery disease market in 2016.

Asia-Pacific is projected to register the highest CAGR of 7.9% during the forecast period, owing to increase in incidence of population suffering from diabetes, obesity, and high blood pressure. In addition, increase in healthcare expenditure and introduction of interventional products such as drug-coated balloon offer a lucrative opportunity for the market growth.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/4315

The major companies profiled in the report include Abbott Laboratories, Boston Scientific Corporation, Cook Medical, Cardinal Health, Inc., C. R. Bard, Inc., Medtronic plc, Terumo Corporation, The Spectranetics Corporation, AngioDynamics, Inc., BIOTRONIK, and B. Braun Melsungen AG.

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.